Stock listing
NASDAQ:PCSC Perceptive Capital Solutions Corp Stock
Home listing (NASDAQ) of Perceptive Capital Solutions Corp
Follow Perceptive Capital Solutions Corp into a list and get an email when it puts out news.

- Ticker
- NASDAQ:PCSC
- Asset type
- Stock
- Sector
- Financials
- Industry
- Shell companies & SPACs
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Jul 9, 2026
Perceptive Capital Solutions Corp Announces Change of Date of Extraordinary General Meeting of Shareholders
Latest deck · Jul 9, 2026
SPAC Merger (July 2026)
SPAC merger · 17 slides
Latest news
Perceptive Capital Solutions Corp on 6ix
- Sector
- Financials
- Industry
- Shell companies & SPACs
- News releases
- 3 in the last 12 months · 4 in all · newest Jul 9, 2026 · oldest 2024
- Decks
- 3 decks · latest Jul 9, 2026
Where Perceptive Capital Solutions Corp is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:PCSC · Home listing · This page | NASDAQ | United States | USD |
| BOATS:PCSC | BOATS | United States | USD |
Valuation
Statements: 4 quarters to Jun 30, 2026
- Enterprise value
- No market cap
- P/E
- No market cap
- EV/sales
- No market cap
- EV/EBITDA
- No market cap
- Price/book
- No market cap
- Gross margin
- Not reported
- Operating margin
- −424.2%
- Net margin
- −92.3%
- Debt to equity
- Negative equity
- Beta vs S&P 500
- Under 6 months of closes
Team and board
Officers
| Officer | Role |
|---|---|
| Aaron Elliott | Chief Executive Officer |
| Deepa Pakianathan | Chief Executive Officer |
| Linh H. Le | Chief Financial Officer |
| Thomas Fitzpatrick | Chief Legal Officer |
| Sally Howard | Senior Vice President, Regulatory and Quality |
| Jimmy Lin | Chief Scientific Officer |
| Julie Tran | Chief People Officer |
| Riley Ennis | Co-Founder and Chief Product Officer |
| Robert Guigley | Chief Commercial Officer |
Board
| Director | Role |
|---|---|
| Douglas VanOort | Director |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q2 2026 | Jul 15, 2026 | +1.3% |
| Q3 2025 | Nov 13, 2025 | |
| Q2 2025 | Aug 13, 2025 | |
| Q1 2025 | May 12, 2025 · After close | |
| Q4 2024 | Mar 19, 2025 |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| SPAC Merger (July 2026) | SPAC merger | 17 slides | Jul 9, 2026 |
| SPAC Merger (May 2026) | SPAC merger | 87 slides | May 19, 2026 |
| SPAC Merger (December 2025) | SPAC merger | 52 slides | Dec 5, 2025 |
Financings
| Raise | Date |
|---|---|
| Private placement of common stock (PIPE) Announced: about US$240M · US$10 a share · Jefferies +1 Dealers: Jefferies (co-lead), Leerink Partners (co-lead) Buyers: Perceptive Advisors; RA Capital; ADAR1 Capital; Bain Capital Life Sciences; Farallon Capital Management Use of proceeds: Develop Freenome's AI/ML multiomics platform, expand commercial and data infrastructure for 2026 test launches, advance multi-cancer detection pipeline | Dec 5, 2025 |
Open Financings · Read by 6ix AI from the company's releases
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | 0 | |
| Selling, general and administrative | 2.98M | 658.7K |
| Operating income | -2.98M | -494.0K |
| Depreciation and amortization | 659 | |
| EBITDA | -493.3K | |
| Income before tax | 837.5K | 1.91M |
| Net income | 837.5K | 1.91M |
| Earnings per share, basic | 0.10 | 0.23 |
Balance sheet
| Line | FY2025 | FY2024 |
|---|---|---|
| Cash and equivalents | 865.0K | 1.13M |
| Current assets | 907.6K | 1.24M |
| Total assets | 92.8M | 89.9M |
| Current liabilities | 2.25M | 210.8K |
| Total liabilities | 5.70M | 3.66M |
| Shareholders' equity | 87.1M | 86.2M |
| Shares outstanding | 8.63M | 8.35M |
Cash flow
| Line | FY2025 | FY2024 |
|---|---|---|
| Cash from operations | -864.7K | -713.3K |
| Capital spending | 0 | 0 |
| Free cash flow | -864.7K | -713.3K |
| Cash from investing | 600.0K | -86.3M |
| Cash from financing | 0 | 88.1M |
| Change in cash | -264.7K | 1.13M |
Cap table
Built by 6ix from Perceptive Capital Solutions Corp’s releases · as of Dec 5, 2025
- Common shares
- 8,157,242
- Fully diluted
- 8,157,242
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 8,157,242 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 8,157,242 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Deepa Pakianathan Other companies: Freenome, Inc. (Chief Executive Officer, a stealth Biotech Company · Since at least Nov 5, 2026); Mereo BioPharma Group plc (Non-Executive Director · Since at least Nov 5, 2026) | Chief Executive Officer · Since at least Nov 5, 2026 |
| Aaron Elliott Other companies: Freenome, Inc. (Chief Executive Officer, Freenome · Since at least Jul 20, 2026) | Chief Executive Officer · Since at least Dec 5, 2025 |
| Douglas VanOort Other companies: Freenome, Inc. (Director · Since at least Nov 5, 2026) | Director · Since at least Nov 5, 2026 |
| Jimmy Lin Other companies: Freenome, Inc. (Chief Scientific Officer · Since at least Nov 4, 2026) | Chief Scientific Officer · Since at least Nov 4, 2026 |
| Julie Tran Other companies: Freenome, Inc. (Chief People Officer · Since at least Nov 5, 2026) | Chief People Officer · Since at least Nov 5, 2026 |
| Linh H. Le Other companies: Freenome, Inc. (Chief Financial Officer · Since at least Nov 5, 2026) | Chief Financial Officer · Since at least Nov 5, 2026 |
| Riley Ennis Other companies: Freenome, Inc. (Co-Founder and Chief Product Officer · Since at least Jul 20, 2026) | Co-Founder and Chief Product Officer · Since at least Nov 5, 2026 |
| Robert Guigley Other companies: Freenome, Inc. (Chief Commercial Officer · Since at least Nov 5, 2026) | Chief Commercial Officer · Since at least Nov 5, 2026 |
| Sally Howard Other companies: Freenome, Inc. (Senior Vice President, Regulatory and Quality · Since at least Nov 5, 2026) | Senior Vice President, Regulatory and Quality · Since at least Nov 5, 2026 |
| Thomas Fitzpatrick Other companies: Freenome, Inc. (Chief Legal Officer · Since at least Nov 5, 2026) | Chief Legal Officer · Since at least Nov 5, 2026 |
Log in to ask 6ix AI your own questions about Perceptive Capital Solutions Corp.